Literature DB >> 10049737

The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs.

T Seidler1, C Pemberton, T Yandle, E Espiner, G Nicholls, M Richards.   

Abstract

We provide the first report of unique leucine zipper-like coiled-coil sequence motifs at the amino terminus (N-) of proBrain Natriuretic Peptide (proBNP) and proAtrial Natriuretic Peptide (proANP). These motifs were highly conserved across most of the known natriuretic peptide sequences from different species. Consistent with computer based modelling predictions, size exclusion (SE) chromatography analysis confirmed human and ovine N-BNP, N-ANP and human proBNP in plasma extracts to elute as high molecular weight oligomers. Synthetic model peptides corresponding to the proposed leucine zipper-like coiled-coil regions of proBNP, proANP and their related N-terminal peptides were shown to be sufficient to induce oligomerisation when assessed on size exclusion HPLC. To our knowledge, this is the first report of circulating peptides that oligomerise through leucine zipper-like coiled-coil motifs, and adds a new dimension to the field of vasoactive peptide research. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049737     DOI: 10.1006/bbrc.1999.0225

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Elif Elmas; Christina Doesch; Stephan Fluechter; Miriam Freundt; Christel Weiss; Siegfried Lang; Thorsten Kälsch; Dariush Haghi; Jana Papassotiriou; Jan Kunde; Stefan O Schoenberg; Martin Borggrefe; Theano Papavassiliu
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-26       Impact factor: 2.357

2.  Reference materials and reference measurement procedures: an overview from a national metrology institute.

Authors:  David M Bunk
Journal:  Clin Biochem Rev       Date:  2007-11

3.  Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure.

Authors:  Adam M Hawkridge; Denise M Heublein; H Robert Bergen; Alessandro Cataliotti; John C Burnett; David C Muddiman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

4.  Current Understanding of the Compensatory Actions of Cardiac Natriuretic Peptides in Cardiac Failure: A Clinical Perspective.

Authors:  Noel S Lee; Lori B Daniels
Journal:  Card Fail Rev       Date:  2016-05

Review 5.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

6.  A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein.

Authors:  Dan L Crimmins; Jeffrey L-F Kao
Journal:  Arch Biochem Biophys       Date:  2008-04-13       Impact factor: 4.013

7.  Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection of brain natriuretic peptide-32 and its proteolytic peptides.

Authors:  Genna L Andrews; Christopher M Shuford; John C Burnett; Adam M Hawkridge; David C Muddiman
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-02-24       Impact factor: 3.205

Review 8.  Natriuretic peptides as biomarkers in heart failure.

Authors:  James L Januzzi
Journal:  J Investig Med       Date:  2013-08       Impact factor: 2.895

Review 9.  A review on B-type natriuretic peptide monitoring: assays and biosensors.

Authors:  Rita Maalouf; Steven Bailey
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

10.  Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patients.

Authors:  Eray Yagmur; Johanna Hermine Sckaer; Ger H Koek; Ralf Weiskirchen; Christian Trautwein; Alexander Koch; Frank Tacke
Journal:  J Transl Med       Date:  2019-12-12       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.